Company Profile

EndoShape Inc
Profile last edited on: 2/27/18      CAGE: 4LRD9      UEI: ZEWENXMMYDK5

Business Identifier: Minimally invasive plugs and coils for occluding blood vessels
Year Founded
2006
First Award
2007
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

5425 Airport Boulevard Suite 101
Boulder, CO 80301
   (303) 416-8849
   rshandas@endoshape.com
   www.endoshape.com
Location: Single
Congr. District: 02
County: Boulder

Public Profile

EndoShape, Inc. is is focused on delivering advances in minimally invasive medical devices through its pioneering efforts in novel shape memory polymer technologies. The firm develops polymer-based minimally invasive medical devices for peripheral vascular, nonvascular, and neurovascular indications. EndoShape utilizes patent-protected materials and products initially developed at the University of Colorado that enable it to solve key and heretofore unsolved clinical issues in the minimally invasive medical device market Organized around improving human health through the development of unique medical devices, Endoshape primary objective is to launch a new class of shape memory polymer based devices that will address minimally invasive treatment and endolumenal applications. EndoShape is seeking to improve embolization procedures for patients and physicians through the application of advanced polymer technology and unique device design.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
15-19
Revenue Range
1.5M-2M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
10-14

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 1 NIH $123,646
Project Title: Radiopaque Shape Memory Polymers for Neurovascular Embolotherapy Applications
2010 2 NSF $673,832
Project Title: Shape memory polymer AAA Endograft
2009 2 NSF $624,000
Project Title: Novel SMP-based TCD Devices
2009 1 NSF $100,000
Project Title: Development of novel SMP-based embolic coils

Key People / Management

  Stephen Hanlon -- President and CTO

  Bill Aldrich -- Chief Executive Officer

  Jeff Castleberry -- COO

  Stephen Goodrich

  Jim Kasic

  Craig Lanning

  Michael Parmenter -- Director, Regulatory Affairs and Quality Assurance

  Julie Trommeter